You are here:
Refine Your Search
Search Again
Search Within
More Results
Records 1 to
25
of 79 records from author Annie Jarabek
2023
Rowan, E., R. Hines, S. Vulimiri, B. Wetmore, C. Brinkerhoff, A. Jarabek, D. Kapraun, E. Kenyon, C. Ring, J. Wambaugh, AND R. Sayre. Constructing An Enzyme Ontogeny Database to Improve Characterization of Toxicokinetic Lifestage Differences (Poster). Society of Toxicology, Nashville, TN, March 19 - 23, 2023. https://doi.org/10.23645/epacomptox.22266274
Rowan, E., R. Hines, Suryanarayana Vulimiri, B. Wetmore, C. Brinkerhoff, A. Jarabek, D. Kapraun, E. Kenyon, C. Ring, J. Wambaugh, AND R. Sayre. Constructing an Enzyme Ontogeny Database to Improve Characterization of Toxicokinetic Lifestage Differences. NC Symposium on Life/Data Sciences, Precision Medicine/Environmental Health, RTP, NC, May 08, 2023. https://doi.org/10.23645/epacomptox.22266274
Jarabek, A. New Approach Methods (NAMs) and lntegrated Approaches to Testing and Assessment (IATA). Toxicology 510 Guest Lecture at the University of Rochester Medical Center, NA, NY, April 13, 2023.
Jarabek, A. Reporting Requirements and Analyses Needed to Establish Confidence in NAMs for Nano-Safety Assessment. HARMLESS General Assembly Spring 2023, Turku, FINLAND, June 14, 2023.
2022
Lee, K., R. Corley, A. Jarabek, N. Kleinstreuer, A. Paini, A. Stucki, AND S. Bell. Advancing New Approach Methodologies (NAMs) for Tobacco Harm Reduction: Synopsis from the 2021 CORESTA SSPT – NAMs symposium. Toxics. MDPI, Basel, Switzerland, , 25, (2022). https://doi.org/10.3390/toxics10120760
Jarabek, A. Computational Models for Risk Assessment of Inhaled Aerosols: History and Conceptual Basis. 2022 International Particulate Toxicology Conference, Sante Fe, NM, August 28 - 31, 2022.
Tedla, G., Ann Jarabek, P. Byrley, W. Boyes, AND K. Rogers. Human exposure to metals in consumer-focused fused filament fabrication (FFF)/ 3D printing processes. SCIENCE OF THE TOTAL ENVIRONMENT. Elsevier BV, AMSTERDAM, Netherlands, 814:152622, (2022). https://doi.org/10.1016/j.scitotenv.2021.152622
Bowers, E., E. Martin, A. Jarabek, D. Morgan, H. Smith, L. Dailey, E. Aungst, D. Diaz-Sanchez, AND S. McCullough. Ozone responsive gene expression as a model for describing repeat exposure response trajectories and inter-individual toxicodynamic variability in vitro. Society of Toxicology Annual Meeting, San Diego, California, March 27 - 31, 2022.
Bowers, E., E. Martin, A. Jarabek, D. Morgan, H. Smith, L. Dailey, E. Aungst, D. Diaz-Sanchez, AND S. McCullough. Ozone responsive gene expression as a model for describing repeat exposure response trajectories and interindividual toxicodynamic variability in vitro. TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA, 185(1):38-49, (2022). https://doi.org/10.1093/toxsci/kfab128
Kapraun, D., P. Schlosser, T. Zurlinden, A. Jarabek, C. Brinkerhoff, AND J. Zhao. RATE Module HSR306 - Quantitative Methods and Models: Dosimetry Adjustments and Pharmacokinetic Concepts. Taiwan EPA RATE Presentations, NA, TAIWAN, PROVINCE OF CHINA, July 13 - 15, 2022.
2021
Byrley, P., W. Boyes, K. Rogers, AND Ann Jarabek. 3D Printer Particle Emissions: Translation to Internal Dose in Adults and Children. JOURNAL OF AEROSOL SCIENCE. Elsevier Science Ltd, New York, NY, 154:1-12, (2021). https://doi.org/10.1016/j.jaerosci.2021.105765
Byrley, P., W. Boyes, K. Rogers, AND Ann Jarabek. 3D Printer Particle Emissions: Translation to Internal Dose in Adults and Children. JOURNAL OF AEROSOL SCIENCE. Elsevier Science Ltd, New York, NY, 154:105765, (2021). https://doi.org/10.1016/j.jaerosci.2021.105765
Jarabek, A. Advancing Application of NAMs and Evidence Integration in Risk Assessment: Dosimetry is Critical to Exposure Alignment. Using in silico and in vitro Approaches for Next Generation Risk Assessment of Potential Respiratory Toxicants, Durham, NC, May 19 - June 02, 2021.
Jarabek, A. Application of Mechanistic Data in Risk Assessment: Exposure Alignment and Evidence Integration. Advancing New Alternative Methods for Tobacco Harm Reduction, Durham, NC, October 18 - 22, 2021.
Jarabek, A. EPA Background Briefing: EPA Multi-path Particle Dosimetry (MPPD) Model 2021 (v. 1.01) Technical Support Documentation & User’s Guide. External Peer Review of the EPA Multi-path Particle Dosimetry (MPPD) Model 2021 (v. 1.01) Technical Support Documentation & User’s Guide, NA, May 04 - 10, 2021.
Jarabek, A. Invited presentation entitled Approaches to Advance the Application of Novel Approach Methods (NAMs) in Evidence Integration for Risk Assessment of Inhaled Agents at the 23rd Congress of the International Society of Aerosols in Medicine (ISAM). 23rd Congress of the International Society of Aerosols in Medicine (ISAM), Boise and virtual, ID, May 22 - 26, 2021.
2020
Price, P., A. Jarabek, AND L. Burgoon. Organizing mechanism-related information on chemical interactions using a framework based on the Aggregate Exposure and Adverse Outcome Pathways. ENVIRONMENT INTERNATIONAL. Elsevier B.V., Amsterdam, Netherlands, 138:105673, (2020). https://doi.org/10.1016/j.envint.2020.105673
Fisher, H., E. Hubal, M. Evans, A. Bunge, A. Jarabek, AND Dan Vallero. Proposed Suite of Models for Estimating Dose Resulting from Exposures by the Dermal Route (SETAC). The Society of Environmental Toxicology and Chemistry (SETAC) North America 41st Annual Meeting, RTP, NC, November 15 - 19, 2020. https://doi.org/10.23645/epacomptox.13503201
Byrley, P., A. Wallace, A. Jarabek, W. Boyes, AND K. Rogers. Recent 3D Printer Emissions Research at EPA. Society for Risk Analysis, NA, Virtual, December 13 - 17, 2020.
Byrley, P., A. Wallace, A. Jarabek, W. Boyes, K. Rogers, AND G. Tedla. Recent 3D Printing Emissions Research at EPA. The Society for Risk Analysis Virtual, Austin, TX, December 13 - 17, 2020.
2019
Hines, D., R. Conolly, AND A. Jarabek. A quantitative approach for integrating mechanistic data across human health and ecological endpoints to inform risk assessment using Aggregate Exposure Pathway and Adverse Outcome Pathway networks. Society of Toxicology, Baltimore, Maryland, March 10 - 14, 2019.
Hines, D., R. Conolly, AND A. Jarabek. A quantitative source-to-outcome case study to demonstrate the integration of human health and ecological endpoints using the Aggregate Exposure Pathway and Adverse Outcome Pathway frameworks. ENVIRONMENTAL SCIENCE & TECHNOLOGY. American Chemical Society, Washington, DC, 53(8):11002-11012, (2019). https://doi.org/10.1021/acs.est.9b04639
Hines, D., R. Conolly, AND Ann Jarabek. Modeling mechanistic processes from source to outcome to support evidence integration and inform risk assessment. NAS Evidence Integration Workshop, Washington, DC, June 03 - 04, 2019.
Whalan, J., J. Stanek, G. Woodall, P. Reinhart, A. Galizia, B. Glenn, A. Kraft, S. Makris, AND A. Jarabek. The Evaluation of Inhalation Studies for Exposure Quality: A Case Study with Formaldehyde. TOXICOLOGY LETTERS. Elsevier Science Ltd, New York, NY, 312:167-172, (2019). https://doi.org/10.1016/j.toxlet.2019.05.011
2018
Hines, D., S. Edwards, R. Conolly, AND A. Jarabek. A Case Study Application of the Aggregate Exposure Pathway (AEP) and Adverse Outcome Pathway (AOP) Frameworks to Facilitate the Integration of Human Health and Ecological End Points for Cumulative Risk Assessment (CRA). ENVIRONMENTAL SCIENCE & TECHNOLOGY. American Chemical Society, Washington, DC, 52(2):839-849, (2018).